Drug intelligence / Profile preview

azathioprine + corticosteroids

Development stage
Unknown
Lead developer
AIIMS New Delhi
Modality
Small Molecules
Administration
Oral, Topical
01

Overview

Azathioprine is an immunosuppressive small molecule that acts as a prodrug for 6-mercaptopurine, which inhibits DNA synthesis and suppresses T-lymphocyte activity. Corticosteroids are a class of steroid hormones that bind to the glucocorticoid receptor to exert potent anti-inflammatory and immunosuppressive effects. This combination regimen is specifically studied by the All India Institute of Medical Sciences (AIIMS) for the treatment of parthenium dermatitis, a severe form of airborne contact dermatitis caused by the weed *Parthenium hysterophorus*. The protocol evaluates the efficacy of azathioprine (administered either as a daily dose or a weekly pulse) in conjunction with topical corticosteroids to induce and maintain disease remission while minimizing the side effects associated with long-term systemic steroid use.

Other names
azathioprine and corticosteroids for Parthenium dermatitis
02

Targets

GR (Glucocorticoid receptor)RAC1 (Rac family small GTPase 1)DNA/RNA (Deoxyribonucleic acid (DNA) and Ribonucleic acid (RNA))

Beyond the preview

Go deeper on azathioprine + corticosteroids.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on azathioprine + corticosteroids.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call